Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

An Open Label International Multi-Center Phase 2 Activity And Safety Study Of SU011248 In Patients With Unresectable Hepatocellular Carcinoma

NCT00247676 is registered in ClinicalTrials.gov with Pfizer as lead sponsor.

NCT NCT00247676
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00247676 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
An Open Label International Multi-Center Phase 2 Activity And Safety Study Of SU011248 In Patients With Unresectable Hepatocellular Carcinoma
Lead sponsor
Pfizer
Phase
Phase 2
Overall status
Completed
Start date
February 28, 2006
Completion date
February 28, 2009
Enrollment
37 (actual)
Sites
8

Conditions

As the registry lists them; a condition with its own page is linked.

liver neoplasms, unresectable hepatocellular carcinoma